发明名称 Use of acylated glycerols and their nitrogen and sulfur analogs for the prevention and treatment of neurodegenerative disorders, e.g. Parkinson's disease
摘要 <p>The use of acylated glycerols, and their nitrogen and sulfur analogs (I), their optical and geometric isomers, racemates, salts, hydrates, and mixtures, for the prevention and treatment of neurodegenerative disorders. The use of acylated glycerols, and their nitrogen and sulfur analogs (I), their optical and geometric isomers, racemates, salts, hydrates, and mixtures, for the prevention and treatment of neurodegenerative disorders. [Image] G1O or N-R; G2, G3O, S, N-R4, with the proviso that G1, G2, and G3 may not simultaneously represent N-R or N-R4; R, R4H or optionally substituted, optionally unsaturated 1-5C alkyl; R1, R2, R3H, CO-R5, CO-(CH2)2n+1-X-R6, with the proviso that at least one is CO-(CH2)2n+1-X-R6; R5optionally substituted, optionally unsaturated, optionally cyclic alkyl having 1-25 C atoms in the main chain; R6optionally substituted, optionally unsaturated, optionally cyclic alkyl having 3-23 C atoms in the main chain and optionally containing one or more hetero groups selected from O, S, Se, SO and SO2; X : S, Se, SO, or SO2; n : 0-11. ACTIVITY : Antiparkinsonian; Nootropic; Neuroprotective. MECHANISM OF ACTION : Alpha Peroxisome Proliferator-Activated Receptor (PPARalpha ) Agonist.</p>
申请公布号 FR2850870(A1) 申请公布日期 2004.08.13
申请号 FR20030001691 申请日期 2003.02.12
申请人 GENFIT S.A. 发明人 DARTEIL RAPHAEL;CAUMONT BERTRAND KARINE;NAJIB JAMILA
分类号 A61K31/045;A61K31/22;A61K31/25;A61K31/265;A61P25/28;(IPC1-7):A61K31/265 主分类号 A61K31/045
代理机构 代理人
主权项
地址